GRAPPA 2025 Annual Meeting: Advances in Psoriatic Disease Research From Pilot Grant Awardees

The Journal of Rheumatology 2026 Open access

Read full text
Authors: Amelie Spangenberg, Tina Bhutani, Lyn D Ferguson, Anaïs Makos, Akihiro Nakamura, Anna Piccinelli, Giovanni Adami, Roshan Amarasena, Paolo Gisondi, Oksana Kehoe, Jan Herman Kuiper, Maurizio Rossini
+5 more Naveed Sattar, Stefan Siebert, Kurt de Vlam, Vinod Chandran, Wilson Liao
DOI: 10.3899/jrheum.2026-0372
Cited by: 1
References: 34

Abstract

Key advances from the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) pilot research grant program were presented at the GRAPPA 2025 annual meeting. Areas of study included hypoxia-inducible factor 1α (HIF1A) as a potential factor in psoriatic arthritis (PsA), plasma extracellular vesicle cytokines as potential biomarkers for predicting response to tumor necrosis factor inhibitors in PsA, bone properties and biomechanics in psoriatic disease (PsD), better understanding of differences in body composition in PsD, and the effect of sleep on PsD severity.

Fields of Study & Subjects

Spondyloarthritis Studies and Treatments Psoriasis: Treatment and Pathogenesis Alkaline Phosphatase Research Studies

Publication details

Journal / source
The Journal of Rheumatology
Publisher
The Journal of Rheumatology
Volume
53
Issue
Suppl 2
Pages
28–32
Publication date
15 May 2026
Language
EN